LL-100 panel

Last updated

The LL-100 panel is a group of 100 human leukemia and lymphoma cell line, [1] can be used in model of biomedical research. [2]

Contents

Purpose

LL-100 panel cell lines cover the full spectrum of human leukemia and lymphoma including T-cell, B-cell and myeloid malignancies. [1]

List of LL-100 Cell Lines

Pre-B-ALL

Cell lineSexAgeRef Cellosaurus
697 Male12Y [3] CVCL_0079
KOPN-8 Female3M [4] CVCL_1866
NALM-6 Male19Y [5] CVCL_0092
REH Female15Y [6] CVCL_1650
SEM Female5Y [7] CVCL_0095

B-NHL: Burkitt/B-ALL

Cell lineSexAgeRef Cellosaurus
BJAB  [ zh ]Female5Y [8] CVCL_5711
Daudi cell  [ zh ]Male16Y [9] CVCL_0008
Raji Male11Y [10] CVCL_0511
RAMOS Male3Y [11] CVCL_0597
VAL Female50Y [12] CVCL_1819

B-NHL: CLL/PLL

Cell lineSexAgeRef Cellosaurus
HG-3 Male70Y [13] CVCL_Y547
JVM-3 Male73Y [14] CVCL_1320
JVM-13 Male60-69Y [15] CVCL_1318
MEC-1 Male61Y [16] CVCL_1870
PGA-1 Maleunspecified [17] CVCL_Y545

B-NHL: DLBCL ABC

Cell lineSexAgeRef Cellosaurus
NU-DHL-1 Male73Y [18] CVCL_1876
OCI-Ly3 Male52Y [19] CVCL_8800
Ri-1 Female57Y [20] CVCL_1885
U-2932 Female29Y [21] CVCL_1896
U-2946 Male52Y [22] CVCL_X503

B-NHL: DLBCL GC

Cell lineSexAgeRef Cellosaurus
DoHH2 Male60Y [23] CVCL_1179
OCI-Ly7 Male48Y [19] CVCL_1881
OCI-Ly19 Female27Y [24] CVCL_1878
SU-DHL-4 Male38Y [25] CVCL_0539
SU-DHL-6 Male43Y [25] CVCL_2206
WSU-DLCL2 Male41Y [26] CVCL_1902

B-NHL: HCL

Cell lineSexAgeRef Cellosaurus
BONNA-12 Male46Y [27] CVCL_1090
Hair-M Male86Y [28] CVCL_B401
HC-1 Male56Y [29] CVCL_1243

B-NHL: MCL

Cell lineSexAgeRef Cellosaurus
Granta-519 Female58Y [30] CVCL_1818
JeKo-1 Female78Y [31] CVCL_1865
JVM-2 Female63Y [14] CVCL_1319
Mino Male68Y [32] CVCL_1872
REC-1 Male61Y [33] CVCL_1884

B-NHL: PEL

Cell lineSexAgeRef Cellosaurus
BC-3 Male85Y [34] CVCL_1080
BCBL-1 Male40Y [35] CVCL_0165
CRO-AP2 Male49Y [36] CVCL_1147
CRO-AP5 Male35Y [37] CVCL_1148

B-NHL: PMBL

Cell lineSexAgeRef Cellosaurus
U-2940 Female18Y [38] CVCL_1897

Multiple Myeloma/PCL

Cell lineSexAgeRef Cellosaurus
KMS-12-BM Female64Y [39] CVCL_1334
L-363 Female36Y [40] CVCL_1357
LP-1 Female56Y [41] CVCL_0012
OPM-2 Female56Y [42] CVCL_1625
RPMI-8226 Male61Y [43] CVCL_0014
U-266 Male53Y [44] CVCL_0566

Hodgkin Lymphoma

Cell lineSexAgeRef Cellosaurus
HDLM-2 Male74Y [45] CVCL_0009
KM-H2 Male37Y [46] CVCL_1330
L-428 Female37Y [45] CVCL_1361
L-1236 Male34Y [47] CVCL_2096
SUP-HD1 Male37Y [48] CVCL_2208

T-ALL/T-LL

Cell lineSexAgeRef Cellosaurus
CCRF-CEM  [ zh ]Female3Y11M [49] CVCL_0207
DND-41  [ zh ]Male13Y [50] CVCL_2022
HPB-ALL Male14Y [51] CVCL_1820
Jurkat Male14Y [52] CVCL_0065
MOLT-4 Male19Y [53] CVCL_0013
RPMI-8402 Female16Y [54] CVCL_1667

Mature T-Malignancy

Cell lineSexAgeRef Cellosaurus
DERL-7 Male30Y [55] CVCL_2017
HH Male61Y [56] CVCL_1280
MOTN-1 Female65Y [57] CVCL_2127

NK Malignancy

Cell lineSexAgeRef Cellosaurus
KHYG-1 Female45Y [58] CVCL_2976
NK-92 Male50Y [59] CVCL_2142
YT Male15Y [60] CVCL_1797

ALCL

Cell lineSexAgeRef Cellosaurus
DEL Male12Y [61] CVCL_1170
SR-786 Male11Y [62] CVCL_1711
SU-DHL-1 Male10Y [63] CVCL_0538
SUP-M2 Female5Y [64] CVCL_2209

AML myelocytic

Cell lineSexAgeRef Cellosaurus
EoL-1  [ zh ]Male33Y [65] CVCL_0258
HL-60 Female36Y [66] CVCL_0002
Kasumi-1 Male7Y [67] CVCL_0589
KG-1  [ zh ]Male59Y [68] CVCL_0374
NB4 Female23Y [69] CVCL_0005
OCI-AML3 Male57Y [70] CVCL_1844
SKNO-1 Male22Y [71] CVCL_2196

AML monocytic

Cell lineSexAgeRef Cellosaurus
ME-1 Male40Y [72] CVCL_2110
MOLM-13 Male20Y [73] CVCL_2119
Mono-Mac-6 Male64Y [74] CVCL_1426
MUTZ-3 Male29Y [75] CVCL_1433
THP-1 Male1Y [76] CVCL_0006
U-937 Male37Y [77] CVCL_0007

AML erythroid

Cell lineSexAgeRef Cellosaurus
F-36P Male68Y [78] CVCL_2037
HEL Male30Y [79] CVCL_0001
OCI-M2 unspecified56Y [80] CVCL_2150
TF-1 Male35Y [81] CVCL_0559

AML megakaryocytic

Cell lineSexAgeRef Cellosaurus
CMK Male10M [82] [83] CVCL_0216
ELF-153 Male41Y [84] CVCL_2031
M-07e Female6M [85] CVCL_2106
MEGAL Femaleunspecified [86] CVCL_1833
MKPL-1 Male66Y [87] CVCL_2116
UT-7 Male64Y [83] CVCL_2233

CML myeloid BC

Cell lineSexAgeRef Cellosaurus
EM-2 Female5Y [88] CVCL_1196
K-562 Female53Y [89] [90] CVCL_0004
KCL-22 Female32Y [91] CVCL_2091
Ku812 Male38Y [92] CVCL_0379
LAMA-84 Female29Y [93] CVCL_0388
MOLM-20 Female63Y [86] CVCL_2121

CML lymphoid BC

Cell lineSexAgeRef Cellosaurus
BV-173 Male45Y [94] CVCL_0181
CML-T1 Female36Y [95] CVCL_1126
NALM-1 Female3Y [96] CVCL_0091
TK-6 Male30Y [97] CVCL_X907

MPN

Cell lineSexAgeRef Cellosaurus
SET-2 Female71Y [98] CVCL_2187

See also

Related Research Articles

<span class="mw-page-title-main">Chronic lymphocytic leukemia</span> Medical condition

Chronic lymphocytic leukemia (CLL) is a type of cancer in which the bone marrow makes too many lymphocytes. Early on, there are typically no symptoms. Later, non-painful lymph node swelling, feeling tired, fever, night sweats, or weight loss for no clear reason may occur. Enlargement of the spleen and low red blood cells (anemia) may also occur. It typically worsens gradually over years.

<span class="mw-page-title-main">Adult T-cell leukemia/lymphoma</span> Human disease

Adult T-cell leukemia/lymphoma is a rare cancer of the immune system's T-cells caused by human T cell leukemia/lymphotropic virus type 1 (HTLV-1). All ATL cells contain integrated HTLV-1 provirus further supporting that causal role of the virus in the cause of the neoplasm. A small amount of HTLV-1 individuals progress to develop ATL with a long latency period between infection and ATL development. ATL is categorized into 4 subtypes: acute, smoldering, lymphoma-type, chronic. Acute and Lymphoma-type are known to particularity be aggressive with poorer prognosis.

<span class="mw-page-title-main">CD30</span> Mammalian protein found in Homo sapiens

CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor family and a tumor marker.

K562 cells were the first human immortalised myelogenous leukemia cell line to be established. K562 cells are of the erythroleukemia type, and the cell line is derived from a 53-year-old female chronic myelogenous leukemia patient in blast crisis. The cells are non-adherent and rounded, are positive for the bcr:abl fusion gene, and bear some proteomic resemblance to both undifferentiated granulocytes and erythrocytes.

Jurkat cells are an immortalized line of human T lymphocyte cells that are used to study acute T cell leukemia, T cell signaling, and the expression of various chemokine receptors susceptible to viral entry, particularly HIV. Jurkat cells can produce interleukin 2, and are used in research involving the susceptibility of cancers to drugs and radiation.

<span class="mw-page-title-main">BCR (gene)</span>

The breakpoint cluster region protein (BCR) also known as renal carcinoma antigen NY-REN-26 is a protein that in humans is encoded by the BCR gene. BCR is one of the two genes in the BCR-ABL fusion protein, which is associated with the Philadelphia chromosome. Two transcript variants encoding different isoforms have been found for this gene.

THP-1 is a human monocytic cell line derived from an acute monocytic leukemia patient. It is used to test leukemia cell lines in immunocytochemical analysis of protein-protein interactions, and immunohistochemistry.

mir-16 microRNA precursor family

The miR-16 microRNA precursor family is a group of related small non-coding RNA genes that regulates gene expression. miR-16, miR-15, mir-195 and miR-497 are related microRNA precursor sequences from the mir-15 gene family. This microRNA family appears to be vertebrate specific and its members have been predicted or experimentally validated in a wide range of vertebrate species.

<span class="mw-page-title-main">Asparagine synthetase</span> Mammalian protein found in Homo sapiens

Asparagine synthetase is a chiefly cytoplasmic enzyme that generates asparagine from aspartate. This amidation reaction is similar to that promoted by glutamine synthetase. The enzyme is ubiquitous in its distribution in mammalian organs, but basal expression is relatively low in tissues other than the exocrine pancreas.

<span class="mw-page-title-main">MN1 (gene)</span> Protein-coding gene in the species Homo sapiens

MN1 is a gene found on human chromosome 22, with gene map locus 22q12.3-qter. Its official full name is meningioma 1 because it is disrupted by a balanced translocation (4;22) in a meningioma.

<span class="mw-page-title-main">CD99</span> Protein-coding gene in humans

CD99 antigen, also known as MIC2 or single-chain type-1 glycoprotein, is a heavily O-glycosylated transmembrane protein that is encoded by the CD99 gene in humans. The protein has a mass of 32 kD. Unusually for a gene present on the X chromosome, the CD99 gene does not undergo X inactivation, and it was the first such pseudoautosomal gene to be discovered in humans.

<span class="mw-page-title-main">RUNX1T1</span> Protein-coding gene in humans

Protein CBFA2T1 is a protein that in humans is encoded by the RUNX1T1 gene.

<span class="mw-page-title-main">Anaplastic lymphoma kinase</span> Protein-coding gene in the species Homo sapiens

Anaplastic lymphoma kinase (ALK) also known as ALK tyrosine kinase receptor or CD246 is an enzyme that in humans is encoded by the ALK gene.

<span class="mw-page-title-main">HOXB6</span> Protein-coding gene in the species Homo sapiens

Homeobox protein Hox-B6 is a protein that in humans is encoded by the HOXB6 gene.

<span class="mw-page-title-main">TLX1</span> Protein coding gene in Humans

T-cell leukemia homeobox protein 1 is a protein that in humans is encoded by the TLX1 gene, which was initially named HOX11.

<span class="mw-page-title-main">AFF3</span> Protein-coding gene in the species Homo sapiens

AF4/FMR2 family member 3 is a protein that in humans is encoded by the AFF3 gene.

Deleted in lymphocytic leukemia 2 is a long non-coding RNA that in humans is encoded by the DLEU2 gene. In humans it is located on chromosome 13q14. The DLEU2 gene was originally identified as a potential tumour suppressor gene and is often deleted in patients with B-cell chronic lymphocytic leukemia.

<span class="mw-page-title-main">CLEC12A</span> Protein-coding gene in humans

C-type lectin domain family 12 member A is a protein that in humans is encoded by the CLEC12A gene.

A20 cells, also called ATCC TIB-208, is a cell line originally derived from B-cell lymphoma in an old BALB/c mouse. AT20 cells are BALB/c lymphoma cells derived from spontaneous reticulum cell neoplasm. ATCC TIB-208 cells originated from B-cell lymphoma in the reticulum cell sarcoma of an elderly BALB/c mouse. A20 cells are used in medical research such as drug screening or vaccine target selection. A20 cells are also highly responsive to immunomodulatory antibodies, and are therefore used frequently in immunotherapy drug studies.

References

  1. 1 2 Quentmeier, H; Pommerenke, C; Dirks, WG; Eberth, S; Koeppel, M; MacLeod, RAF; Nagel, S; Steube, K; Uphoff, CC; Drexler, HG (3 June 2019). "The LL-100 panel: 100 cell lines for blood cancer studies". Scientific Reports. 9 (1): 8218. Bibcode:2019NatSR...9.8218Q. doi:10.1038/s41598-019-44491-x. PMC   6547646 . PMID   31160637.
  2. ↑ Drexler, HG; Quentmeier, H (13 August 2020). "The LL-100 Cell Lines Panel: Tool for Molecular Leukemia-Lymphoma Research". International Journal of Molecular Sciences. 21 (16): 5800. doi: 10.3390/ijms21165800 . PMC   7461097 . PMID   32823535.
  3. ↑ Findley HW, Jr; Cooper, MD; Kim, TH; Alvarado, C; Ragab, AH (December 1982). "Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes". Blood. 60 (6): 1305–9. doi: 10.1182/blood.V60.6.1305.1305 . PMID   6982733.
  4. ↑ Uphoff, CC; MacLeod, RA; Denkmann, SA; Golub, TR; Borkhardt, A; Janssen, JW; Drexler, HG (March 1997). "Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines". Leukemia. 11 (3): 441–7. doi:10.1038/sj.leu.2400571. PMID   9067587. S2CID   37823510.
  5. ↑ Hurwitz, R; Hozier, J; LeBien, T; Minowada, J; Gajl-Peczalska, K; Kubonishi, I; Kersey, J (February 1979). "Characterization of a leukemic cell line of the pre-B phenotype". International Journal of Cancer. 23 (2): 174–80. doi:10.1002/ijc.2910230206. PMID   83966. S2CID   29853203.
  6. ↑ Rosenfeld, C; Goutner, A; Venuat, AM; Choquet, C; Pico, JL; Dore, JF; Liabeuf, A; Durandy, A; Desgrange, C; De The, G (April 1977). "An effect human leukaemic cell line: Reh". European Journal of Cancer. 13 (4–5): 377–9. doi:10.1016/0014-2964(77)90085-8. PMID   194778.
  7. ↑ Greil, J; Gramatzki, M; Burger, R; Marschalek, R; Peltner, M; Trautmann, U; Hansen-Hagge, TE; Bartram, CR; Fey, GH; Stehr, K (February 1994). "The acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7". British Journal of Haematology. 86 (2): 275–83. doi:10.1111/j.1365-2141.1994.tb04726.x. PMID   8199015. S2CID   44321104.
  8. ↑ Menezes, J; Leibold, W; Klein, G; Clements, G (July 1975). "Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma". Biomédicine. 22 (4): 276–84. PMID   179629.
  9. ↑ Nadkarni, JS; Nadkarni, JJ; Clifford, P; Manolov, G; Fenyö, EM; Klein, E (January 1969). "Characteristics of new cell lines derived from Burkitt lymphomas". Cancer. 23 (1): 64–79. doi: 10.1002/1097-0142(196901)23:1<64::aid-cncr2820230107>3.0.co;2-m . PMID   4178827. S2CID   46405882.
  10. ↑ PULVERTAFT, JV (1 February 1964). "Cytology of Burkitt's Tumour (African Lymphoma)". Lancet. 1 (7327): 238–40. doi:10.1016/s0140-6736(64)92345-1. PMID   14086209.
  11. ↑ Klein, G; Giovanella, B; Westman, A; Stehlin, JS; Mumford, D (1975). "An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection". Intervirology. 5 (6): 319–34. doi:10.1159/000149930. PMID   181343.
  12. ↑ Kerckaert, JP; Deweindt, C; Tilly, H; Quief, S; Lecocq, G; Bastard, C (September 1993). "LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas". Nature Genetics. 5 (1): 66–70. doi:10.1038/ng0993-66. PMID   8220427. S2CID   12575122.
  13. ↑ Rosén, A; Bergh, AC; Gogok, P; Evaldsson, C; Myhrinder, AL; Hellqvist, E; Rasul, A; Björkholm, M; Jansson, M; Mansouri, L; Liu, A; Teh, BT; Rosenquist, R; Klein, E (1 January 2012). "Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection". Oncoimmunology. 1 (1): 18–27. doi:10.4161/onci.1.1.18400. PMC   3376971 . PMID   22720208.
  14. 1 2 Melo, JV; Brito-Babapulle, V; Foroni, L; Robinson, DS; Luzzatto, L; Catovsky, D (15 October 1986). "Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement". International Journal of Cancer. 38 (4): 531–8. doi:10.1002/ijc.2910380413. PMID   3093393. S2CID   10813284.
  15. ↑ Melo, JV; Foroni, L; Brito-Babapulle, V; Luzzatto, L; Catovsky, D (July 1988). "The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangement". Clinical and Experimental Immunology. 73 (1): 23–8. PMC   1541467 . PMID   3262465.
  16. ↑ Stacchini, A; Aragno, M; Vallario, A; Alfarano, A; Circosta, P; Gottardi, D; Faldella, A; Rege-Cambrin, G; Thunberg, U; Nilsson, K; Caligaris-Cappio, F (February 1999). "MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation". Leukemia Research. 23 (2): 127–36. doi:10.1016/s0145-2126(98)00154-4. PMID   10071128.
  17. ↑ Lewin, N; Aman, P; Mellstedt, H; Zech, L; Klein, G (15 June 1988). "Direct outgrowth of in vivo Epstein-Barr virus (EBV)-infected chronic lymphocytic leukemia (CLL) cells into permanent lines". International Journal of Cancer. 41 (6): 892–5. doi:10.1002/ijc.2910410621. PMID   2836321. S2CID   38575113.
  18. ↑ Epstein, AL; Variakojis, D; Berger, C; Hecht, BK (15 May 1985). "Use of novel chemical supplements in the establishment of three human malignant lymphoma cell lines (NU-DHL-1, NU-DUL-1, and NU-AMB-1) with chromosome 14 translocations". International Journal of Cancer. 35 (5): 619–27. doi:10.1002/ijc.2910350509. PMID   2581902. S2CID   38530935.
  19. 1 2 Tweeddale, ME; Lim, B; Jamal, N; Robinson, J; Zalcberg, J; Lockwood, G; Minden, MD; Messner, HA (May 1987). "The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor". Blood. 69 (5): 1307–14. doi: 10.1182/blood.V69.5.1307.1307 . PMID   3567358.
  20. ↑ Th'ng, KH; Garewal, G; Kearney, L; Rassool, F; Melo, JV; White, H; Catovsky, D; Foroni, L; Luzzatto, L; Goldman, JM (15 January 1987). "Establishment and characterization of three new malignant lymphoid cell lines". International Journal of Cancer. 39 (1): 89–93. doi:10.1002/ijc.2910390116. PMID   3098690. S2CID   23849509.
  21. ↑ Amini, RM; Berglund, M; Rosenquist, R; Von Heideman, A; Lagercrantz, S; Thunberg, U; Bergh, J; Sundström, C; Glimelius, B; Enblad, G (November 2002). "A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma". Leukemia & Lymphoma. 43 (11): 2179–89. doi:10.1080/1042819021000032917. PMID   12533045. S2CID   23476994.
  22. ↑ Fridberg, M; Servin, A; Anagnostaki, L; Linderoth, J; Berglund, M; Söderberg, O; Enblad, G; Rosén, A; Mustelin, T; Jerkeman, M; Persson, JL; Wingren, AG (November 2007). "Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN". Leukemia & Lymphoma. 48 (11): 2221–32. doi:10.1080/10428190701636443. PMID   17926183. S2CID   17523509.
  23. ↑ Kluin-Nelemans, HC; Limpens, J; Meerabux, J; Beverstock, GC; Jansen, JH; de Jong, D; Kluin, PM (March 1991). "A new non-Hodgkin's B-cell line (DoHH2) with a chromosomal translocation t(14;18)(q32;q21)". Leukemia. 5 (3): 221–4. PMID   1849602.
  24. ↑ Chang, H; Blondal, JA; Benchimol, S; Minden, MD; Messner, HA (September 1995). "p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines". Leukemia & Lymphoma. 19 (1–2): 165–71. doi:10.3109/10428199509059672. PMID   8574164.
  25. 1 2 Epstein, AL; Herman, MM; Kim, H; Dorfman, RF; Kaplan, HS (May 1976). "Biology of the human malignant lymphomas. III. Intracranial heterotransplantation in the nude, athymic mouse". Cancer. 37 (5): 2158–76. doi:10.1002/1097-0142(197605)37:5<2158::aid-cncr2820370503>3.0.co;2-f. PMID   177185. S2CID   6013844.
  26. ↑ Al-Katib, AM; Smith, MR; Kamanda, WS; Pettit, GR; Hamdan, M; Mohamed, AN; Chelladurai, B; Mohammad, RM (May 1998). "Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts". Clinical Cancer Research. 4 (5): 1305–14. PMID   9607591.
  27. ↑ Wientjens, GJ; Jansen, JH; Wessels, HW; Kibbelaar, RE; Beverstock, GC; Brederoo, P; Kluin-Nelemans, HC (1991). "Characterization of a New Human B Cell Line (Bonna-12) with Trisomy 9 and Trisomy 12 Chromosomal Abnormality". Leukemia & Lymphoma. 5 (5–6): 415–22. doi:10.3109/10428199109067637. PMID   27463354.
  28. ↑ Matsuo, Y; Sagawa, K; Yokoyama, M; Koga, T; Yamaguchi, T; Morita, M; Minowada, J (November 1983). "[Establishment and characterization of hairy cell leukemia cell line (Hair-M)]". Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society. 46 (6): 1222–32. PMID   6608852.
  29. ↑ Schiller, JH; Bittner, G; Meisner, LF; Oberley, TD; Norback, D; Schwabe, M; Faltynek, CR; Raab-Traub, N (May 1991). "Establishment and characterization of an Epstein-Barr virus spontaneously transformed lymphocytic cell line derived from a hairy cell leukemia patient". Leukemia. 5 (5): 399–407. PMID   1851909.
  30. ↑ Lukas, J; Jadayel, D; Bartkova, J; Nacheva, E; Dyer, MJ; Strauss, M; Bartek, J (August 1994). "BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation". Oncogene. 9 (8): 2159–67. PMID   8036001.
  31. ↑ Jeon, HJ; Kim, CW; Yoshino, T; Akagi, T (September 1998). "Establishment and characterization of a mantle cell lymphoma cell line". British Journal of Haematology. 102 (5): 1323–6. doi: 10.1046/j.1365-2141.1998.00911.x . PMID   9753063. S2CID   29818033.
  32. ↑ Lai, R; McDonnell, TJ; O'Connor, SL; Medeiros, LJ; Oudat, R; Keating, M; Morgan, MB; Curiel, TJ; Ford, RJ (September 2002). "Establishment and characterization of a new mantle cell lymphoma cell line, Mino". Leukemia Research. 26 (9): 849–55. doi:10.1016/s0145-2126(02)00013-9. PMID   12127561.
  33. ↑ Szepetowski, P; Simon, MP; Grosgeorge, J; Huebner, K; Bastard, C; Evans, GA; Tsujimoto, Y; Birnbaum, D; Theillet, C; Gaudray, P (April 1992). "Localization of 11q13 loci with respect to regional chromosomal breakpoints". Genomics. 12 (4): 738–44. doi:10.1016/0888-7543(92)90303-a. PMID   1572647.
  34. ↑ Arvanitakis, L; Mesri, EA; Nador, RG; Said, JW; Asch, AS; Knowles, DM; Cesarman, E (1 October 1996). "Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus". Blood. 88 (7): 2648–54. doi: 10.1182/blood.V88.7.2648.bloodjournal8872648 . PMID   8839859.
  35. ↑ Renne, R; Zhong, W; Herndier, B; McGrath, M; Abbey, N; Kedes, D; Ganem, D (March 1996). "Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture". Nature Medicine. 2 (3): 342–6. doi:10.1038/nm0396-342. PMID   8612236. S2CID   20384290.
  36. ↑ Carbone, A; Cilia, AM; Gloghini, A; Canzonieri, V; Pastore, C; Todesco, M; Cozzi, M; Perin, T; Volpe, R; Pinto, A; Gaidano, G (14 November 1997). "Establishment of HHV-8-positive and HHV-8-negative lymphoma cell lines from primary lymphomatous effusions". International Journal of Cancer. 73 (4): 562–9. doi:10.1002/(sici)1097-0215(19971114)73:4<562::aid-ijc18>3.0.co;2-b. PMID   9389573. S2CID   32367275.
  37. ↑ Carbone, A; Cilia, AM; Gloghini, A; Capello, D; Todesco, M; Quattrone, S; Volpe, R; Gaidano, G (September 1998). "Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8". British Journal of Haematology. 102 (4): 1081–9. doi: 10.1046/j.1365-2141.1998.00877.x . PMID   9734661. S2CID   23440348.
  38. ↑ Sambade, C; Berglund, M; Lagercrantz, S; Sällström, J; Reis, RM; Enblad, G; Glimelius, B; Sundström, C (1 February 2006). "U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma". International Journal of Cancer. 118 (3): 555–63. doi: 10.1002/ijc.21417 . PMID   16106419. S2CID   12837372.
  39. ↑ Ohtsuki, T; Yawata, Y; Wada, H; Sugihara, T; Mori, M; Namba, M (October 1989). "Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32)". British Journal of Haematology. 73 (2): 199–204. doi:10.1111/j.1365-2141.1989.tb00252.x. PMID   2479409. S2CID   29676750.
  40. ↑ Diehl, V; Schaadt, M; Kirchner, H; Hellriegel, KP; Gudat, F; Fonatsch, C; Laskewitz, E; Guggenheim, R (20 June 1978). "Long-term cultivation of plasma cell leukemia cells and autologous lymphoblasts (LCL) in vitro: a comparative study". Blut. 36 (6): 331–8. doi:10.1007/BF01000590. PMID   207377. S2CID   22828123.
  41. ↑ Pegoraro, L; Malavasi, F; Bellone, G; Massaia, M; Boccadoro, M; Saglio, G; Guerrasio, A; Benetton, G; Lombardi, L; Coda, R (March 1989). "The human myeloma cell line LP-1: a versatile model in which to study early plasma-cell differentiation and c-myc activation". Blood. 73 (4): 1020–7. doi: 10.1182/blood.V73.4.1020.1020 . PMID   2784066.
  42. ↑ Katagiri, S; Yonezawa, T; Kuyama, J; Kanayama, Y; Nishida, K; Abe, T; Tamaki, T; Ohnishi, M; Tarui, S (15 August 1985). "Two distinct human myeloma cell lines originating from one patient with myeloma". International Journal of Cancer. 36 (2): 241–6. doi:10.1002/ijc.2910360217. PMID   3926660. S2CID   20506312.
  43. ↑ Matsuoka, Y; Moore, GE; Yagi, Y; Pressman, D (August 1967). "Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma". Proceedings of the Society for Experimental Biology and Medicine. 125 (4): 1246–50. doi:10.3181/00379727-125-32327. PMID   6042436. S2CID   9643262.
  44. ↑ Nilsson, K; Bennich, H; Johansson, SG; Pontén, J (October 1970). "Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient". Clinical and Experimental Immunology. 7 (4): 477–89. PMC   1712861 . PMID   4097745.
  45. 1 2 Drexler, HG; Gaedicke, G; Lok, MS; Diehl, V; Minowada, J (1986). "Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles". Leukemia Research. 10 (5): 487–500. doi:10.1016/0145-2126(86)90084-6. PMID   3713248.
  46. ↑ Kamesaki, H; Fukuhara, S; Tatsumi, E; Uchino, H; Yamabe, H; Miwa, H; Shirakawa, S; Hatanaka, M; Honjo, T (July 1986). "Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease". Blood. 68 (1): 285–92. doi: 10.1182/blood.V68.1.285.285 . PMID   3013343.
  47. ↑ Wolf, J; Kapp, U; Bohlen, H; Kornacker, M; Schoch, C; Stahl, B; Mücke, S; von Kalle, C; Fonatsch, C; Schaefer, HE; Hansmann, ML; Diehl, V (15 April 1996). "Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells". Blood. 87 (8): 3418–28. doi: 10.1182/blood.V87.8.3418.bloodjournal8783418 . PMID   8605360.
  48. ↑ Naumovski, L; Utz, PJ; Bergstrom, SK; Morgan, R; Molina, A; Toole, JJ; Glader, BE; McFall, P; Weiss, LM; Warnke, R (December 1989). "SUP-HD1: a new Hodgkin's disease-derived cell line with lymphoid features produces interferon-gamma". Blood. 74 (8): 2733–42. doi: 10.1182/blood.V74.8.2733.2733 . PMID   2554995.
  49. ↑ FOLEY, GE; LAZARUS, H; FARBER, S; UZMAN, BG; BOONE, BA; MCCARTHY, RE (April 1965). "Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia". Cancer. 18 (4): 522–9. doi: 10.1002/1097-0142(196504)18:4<522::aid-cncr2820180418>3.0.co;2-j . PMID   14278051. S2CID   32647486.
  50. ↑ Heyman, M; Grandér, D; Bröndum-Nielsen, K; Cederblad, B; Liu, Y; Xu, B; Einhorn, S (March 1994). "Interferon system defects in malignant T-cells". Leukemia. 8 (3): 425–34. PMID   8127147.
  51. ↑ Morikawa, S; Tatsumi, E; Baba, M; Harada, T; Yasuhira, K (15 February 1978). "Two E-rosette-forming lymphoid cell lines". International Journal of Cancer. 21 (2): 166–70. doi:10.1002/ijc.2910210207. PMID   203546. S2CID   9032666.
  52. ↑ Abraham, RT; Weiss, A (April 2004). "Jurkat T cells and development of the T-cell receptor signalling paradigm". Nature Reviews. Immunology. 4 (4): 301–8. doi:10.1038/nri1330. PMID   15057788. S2CID   13253575.
  53. ↑ Minowada, J; Onuma, T; Moore, GE (September 1972). "Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes". Journal of the National Cancer Institute. 49 (3): 891–5. PMID   4567231.
  54. ↑ Huang, CC; Hou, Y; Woods, LK; Moore, GE; Minowada, J (September 1974). "Cytogenetic study of human lymphoid T-cell lines derived from lymphocytic leukemia". Journal of the National Cancer Institute. 53 (3): 655–60. doi:10.1093/jnci/53.3.655. PMID   4547172.
  55. ↑ Di Noto, R; Pane, F; Camera, A; Luciano, L; Barone, M; Lo Pardo, C; Boccuni, P; Intrieri, M; Izzo, B; Villa, MR; Macrí, M; Rotoli, B; Sacchetti, L; Salvatore, F; Del Vecchio, L (October 2001). "Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/Tcry5+) and DERL-7 (CD56+/CD3-/TCRgammadelta-), derived from a single patient with CD56+ non-Hodgkin's lymphoma". Leukemia. 15 (10): 1641–9. doi:10.1038/sj.leu.2402239. PMID   11587224. S2CID   25177712.
  56. ↑ Starkebaum, G; Loughran TP, Jr; Waters, CA; Ruscetti, FW (9 September 1991). "Establishment of an IL-2 independent, human T-cell line possessing only the p70 IL-2 receptor". International Journal of Cancer. 49 (2): 246–53. doi:10.1002/ijc.2910490218. PMID   1879969. S2CID   8605186.
  57. ↑ Matsuo, Y; Drexler, HG; Takeuchi, M; Tanaka, M; Orita, K (September 2002). "Establishment of the T-cell large granular lymphocyte leukemia cell line MOTN-1 carrying natural killer-cell antigens". Leukemia Research. 26 (9): 873–9. doi:10.1016/s0145-2126(02)00023-1. PMID   12127564.
  58. ↑ Yagita, M; Huang, CL; Umehara, H; Matsuo, Y; Tabata, R; Miyake, M; Konaka, Y; Takatsuki, K (May 2000). "A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation". Leukemia. 14 (5): 922–30. doi:10.1038/sj.leu.2401769. PMID   10803526. S2CID   22938275.
  59. ↑ Gong, J., Maki, G., and Klingemann, H-G. (1994). “Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells”. Leukemia; 8: 652-58.
  60. ↑ Yodoi, J; Teshigawara, K; Nikaido, T; Fukui, K; Noma, T; Honjo, T; Takigawa, M; Sasaki, M; Minato, N; Tsudo, M (March 1985). "TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells)". Journal of Immunology. 134 (3): 1623–30. doi: 10.4049/jimmunol.134.3.1623 . PMID   2578514. S2CID   13147698.
  61. ↑ Barbey, S; Gogusev, J; Mouly, H; Le Pelletier, O; Smith, W; Richard, S; Soulie, J; Nezelof, C (15 March 1990). "DEL cell line: a "malignant histiocytosis" CD30+ t(5;6)(q35;p21) cell line". International Journal of Cancer. 45 (3): 546–53. doi:10.1002/ijc.2910450329. PMID   2307542. S2CID   1472373.
  62. ↑ Su, IJ; Balk, SP; Kadin, ME (August 1988). "Molecular basis for the aberrant expression of T cell antigens in postthymic T cell malignancies". The American Journal of Pathology. 132 (2): 192–8. PMC   1880737 . PMID   2456698.
  63. ↑ Epstein, AL; Kaplan, HS (December 1974). "Biology of the human malignant lymphomas. I. Establishment in continuous cell culture and heterotransplantation of diffuse histiocytic lymphomas". Cancer. 34 (6): 1851–72. doi: 10.1002/1097-0142(197412)34:6<1851::aid-cncr2820340602>3.0.co;2-4 . PMID   4140017. S2CID   27701046.
  64. ↑ Morgan, R; Smith, SD; Hecht, BK; Christy, V; Mellentin, JD; Warnke, R; Cleary, ML (June 1989). "Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis". Blood. 73 (8): 2155–64. doi: 10.1182/blood.V73.8.2155.2155 . PMID   2525056.
  65. ↑ Mayumi, M (June 1992). "EoL-1, a human eosinophilic cell line". Leukemia & Lymphoma. 7 (3): 243–50. doi:10.3109/10428199209053629. PMID   1477652. Archived from the original on 2019-12-23. Retrieved 2019-12-23.
  66. ↑ Gallagher, R; Collins, S; Trujillo, J; McCredie, K; Ahearn, M; Tsai, S; Metzgar, R; Aulakh, G; Ting, R; Ruscetti, F; Gallo, R (September 1979). "Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia". Blood. 54 (3): 713–33. doi: 10.1182/blood.V54.3.713.713 . PMID   288488.
  67. ↑ Asou, H; Tashiro, S; Hamamoto, K; Otsuji, A; Kita, K; Kamada, N (1 May 1991). "Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation". Blood. 77 (9): 2031–6. doi: 10.1182/blood.V77.9.2031.2031 . PMID   2018839.
  68. ↑ Mrózek, K; Tanner, SM; Heinonen, K; Bloomfield, CD (November 2003). "Molecular cytogenetic characterization of the KG-1 and KG-1a acute myeloid leukemia cell lines by use of spectral karyotyping and fluorescence in situ hybridization". Genes, Chromosomes & Cancer. 38 (3): 249–52. doi:10.1002/gcc.10274. PMID   14506699. S2CID   6018408.
  69. ↑ Lanotte, M; Martin-Thouvenin, V; Najman, S; Balerini, P; Valensi, F; Berger, R (1 March 1991). "NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)". Blood. 77 (5): 1080–6. doi: 10.1182/blood.V77.5.1080.1080 . PMID   1995093.
  70. ↑ Wang, C; Curtis, JE; Minden, MD; McCulloch, EA (April 1989). "Expression of a retinoic acid receptor gene in myeloid leukemia cells". Leukemia. 3 (4): 264–9. PMID   2538684.
  71. ↑ Matozaki, S; Nakagawa, T; Kawaguchi, R; Aozaki, R; Tsutsumi, M; Murayama, T; Koizumi, T; Nishimura, R; Isobe, T; Chihara, K (April 1995). "Establishment of a myeloid leukaemic cell line (SKNO-1) from a patient with t(8;21) who acquired monosomy 17 during disease progression". British Journal of Haematology. 89 (4): 805–11. doi:10.1111/j.1365-2141.1995.tb08418.x. PMID   7772516. S2CID   40610063.
  72. ↑ Yanagisawa, K; Horiuchi, T; Fujita, S (15 July 1991). "Establishment and characterization of a new human leukemia cell line derived from M4E0". Blood. 78 (2): 451–7. doi: 10.1182/blood.V78.2.451.451 . PMID   2070080.
  73. ↑ Matsuo, Y; MacLeod, RA; Uphoff, CC; Drexler, HG; Nishizaki, C; Katayama, Y; Kimura, G; Fujii, N; Omoto, E; Harada, M; Orita, K (September 1997). "Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23)". Leukemia. 11 (9): 1469–77. doi:10.1038/sj.leu.2400768. PMID   9305600. S2CID   205678428.
  74. ↑ Ziegler-Heitbrock, HW; Thiel, E; Fütterer, A; Herzog, V; Wirtz, A; Riethmüller, G (15 March 1988). "Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes". International Journal of Cancer. 41 (3): 456–61. doi:10.1002/ijc.2910410324. PMID   3162233. S2CID   23268646.
  75. ↑ Hu, ZB; Ma, W; Zaborski, M; MacLeod, R; Quentmeier, H; Drexler, HG (June 1996). "Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3". Leukemia. 10 (6): 1025–40. PMID   8667638.
  76. ↑ Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K (August 1980). "Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)". International Journal of Cancer. 26 (2): 171–6. doi:10.1002/ijc.2910260208. PMID   6970727. S2CID   43603660.
  77. ↑ Sundström C (May 1976). "Establishment and characterization of a human histiocytic lymphoma cell line (U-937)". Int. J. Cancer. 17 (5): 565–77. doi:10.1002/ijc.2910170504. PMID   178611. S2CID   19334036.
  78. ↑ Chiba, S; Takaku, F; Tange, T; Shibuya, K; Misawa, C; Sasaki, K; Miyagawa, K; Yazaki, Y; Hirai, H (1 November 1991). "Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: a parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin". Blood. 78 (9): 2261–8. doi: 10.1182/blood.V78.9.2261.2261 . PMID   1834251.
  79. ↑ Martin, P; Papayannopoulou, T (1982-06-11). "HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression". Science. 216 (4551): 1233–5. Bibcode:1982Sci...216.1233M. doi:10.1126/science.6177045. PMID   6177045.
  80. ↑ Papayannopoulou, T; Nakamoto, B; Kurachi, S; Tweeddale, M; Messner, H (September 1988). "Surface antigenic profile and globin phenotype of two new human erythroleukemia lines: characterization and interpretations". Blood. 72 (3): 1029–38. doi: 10.1182/blood.V72.3.1029.bloodjournal7231029 . PMID   3166384.
  81. ↑ Kitamura, T; Tange, T; Terasawa, T; Chiba, S; Kuwaki, T; Miyagawa, K; Piao, YF; Miyazono, K; Urabe, A; Takaku, F (August 1989). "Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin". Journal of Cellular Physiology. 140 (2): 323–34. doi:10.1002/jcp.1041400219. PMID   2663885. S2CID   44794601.
  82. ↑ Sato, T; Fuse, A; Eguchi, M; Hayashi, Y; Ryo, R; Adachi, M; Kishimoto, Y; Teramura, M; Mizoguchi, H; Shima, Y (June 1989). "Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia". British Journal of Haematology. 72 (2): 184–90. doi:10.1111/j.1365-2141.1989.tb07681.x. PMID   2527057. S2CID   9036646.
  83. 1 2 Miura, Y; Komatsu, N; Suda, T (1990). "Growth and differentiation of two human megakaryoblastic cell lines; CMK and UT-7". Progress in Clinical and Biological Research. 356: 259–70. PMID   2217443.
  84. ↑ Mouthon, MA; Freund, M; Titeux, M; Katz, A; Guichard, J; Breton-Gorius, J; Vainchenker, W (15 August 1994). "Growth and differentiation of the human megakaryoblastic cell line (ELF-153): a model for early stages of megakaryocytopoiesis". Blood. 84 (4): 1085–97. doi: 10.1182/blood.V84.4.1085.1085 . PMID   7519473.
  85. ↑ Avanzi, GC; Brizzi, MF; Giannotti, J; Ciarletta, A; Yang, YC; Pegoraro, L; Clark, SC (December 1990). "M-07e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3". Journal of Cellular Physiology. 145 (3): 458–64. doi:10.1002/jcp.1041450310. PMID   2273055. S2CID   39079797.
  86. 1 2 Quentmeier, H; MacLeod, RA; Zaborski, M; Drexler, HG (March 2006). "JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders". Leukemia. 20 (3): 471–6. doi:10.1038/sj.leu.2404081. PMID   16408098. S2CID   1907521.
  87. ↑ Takeuchi, S; Sugito, S; Uemura, Y; Miyagi, T; Kubonishi, I; Taguchi, H; Enzan, H; Ohtsuki, Y; Miyoshi, I (June 1992). "Acute megakaryoblastic leukemia: establishment of a new cell line (MKPL-1) in vitro and in vivo". Leukemia. 6 (6): 588–94. PMID   1602796.
  88. ↑ Raskind, WH; Disteche, CM; Keating, A; Singer, JW (April 1987). "Correlation between cytogenetic and molecular findings in human chronic myelogenous leukemia lines EM-2 and EM-3". Cancer Genetics and Cytogenetics. 25 (2): 271–84. doi:10.1016/0165-4608(87)90188-9. PMID   3030532.
  89. ↑ Lozzio CB, Lozzio BB (March 1975). "Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome". Blood. 45 (3): 321–334. doi: 10.1182/blood.V45.3.321.321 . PMID   163658.
  90. ↑ Drexler HG (2000). The Leukemia-Lymphoma Cell Line Factsbook. San Diego: Academic Press.
  91. ↑ Kubonishi, I; Miyoshi, I (June 1983). "Establishment of a Ph1 chromosome-positive cell line from chronic myelogenous leukemia in blast crisis". International Journal of Cell Cloning. 1 (2): 105–17. doi:10.1002/stem.5530010205. PMID   6321612.
  92. ↑ Kishi, K (1985). "A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors". Leukemia Research. 9 (3): 381–90. doi:10.1016/0145-2126(85)90060-8. PMID   3858609.
  93. ↑ Seigneurin, D; Champelovier, P; Mouchiroud, G; Berthier, R; Leroux, D; Prenant, M; McGregor, J; Starck, J; Morle, F; Micouin, C (September 1987). "Human chronic myeloid leukemic cell line with positive Philadelphia chromosome exhibits megakaryocytic and erythroid characteristics". Experimental Hematology. 15 (8): 822–32. PMID   3476310.
  94. ↑ Pegoraro, L; Matera, L; Ritz, J; Levis, A; Palumbo, A; Biagini, G (March 1983). "Establishment of a Ph1-positive human cell line (BV173)". Journal of the National Cancer Institute. 70 (3): 447–53. PMID   6572735.
  95. ↑ Kuriyama, K; Gale, RP; Tomonaga, M; Ikeda, S; Yao, E; Klisak, I; Whelan, K; Yakir, H; Ichimaru, M; Sparkes, RS (September 1989). "CML-T1: a cell line derived from T-lymphocyte acute phase of chronic myelogenous leukemia". Blood. 74 (4): 1381–7. doi: 10.1182/blood.V74.4.1381.1381 . PMID   2788468. S2CID   16883925.
  96. ↑ Minowada, J; Tsubota, T; Greaves, MF; Walters, TR (July 1977). "A non-T, non-B human leukemia cell line (NALM-1): establishment of the cell line and presence of leukemia-associated antigens". Journal of the National Cancer Institute. 59 (1): 83–7. doi:10.1093/jnci/59.1.83. PMID   301573.
  97. ↑ Watanabe, T; Kataoka, T; Mizuta, S; Kobayashi, M; Uchida, T; Imai, K; Wada, H; Kinoshita, T; Murate, T; Mizutani, S (November 1995). "Establishment and characterization of a novel cell line, TK-6, derived from T cell blast crisis of chronic myelogenous leukemia, with the secretion of parathyroid hormone-related protein". Leukemia. 9 (11): 1926–34. PMID   7475285.
  98. ↑ Uozumi, K; Otsuka, M; Ohno, N; Moriyama, T; Suzuki, S; Shimotakahara, S; Matsumura, I; Hanada, S; Arima, T (January 2000). "Establishment and characterization of a new human megakaryoblastic cell line (SET-2) that spontaneously matures to megakaryocytes and produces platelet-like particles". Leukemia. 14 (1): 142–52. doi:10.1038/sj.leu.2401608. PMID   10637490. S2CID   3258153.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.